Sanofi trounces own price record with Eu500m tap

French pharmaceutical company Sanofi-aventis tapped an outstanding 2014 bond this week in a deal priced at just 20bp over mid-swaps. This was the tightest level any corporate issuer in Europe has been able to access the market at after Lehman Brothers’ collapse — since Sanofi-aventis itself last broke that record.